HILLHOUSE INVESTMENT MANAGEMENT, LTD.'s Net Worth
$23 Billion
Who is HILLHOUSE INVESTMENT MANAGEMENT, LTD.?
HILLHOUSE INVESTMENT MANAGEMENT, LTD. has an estimated net worth of $23 Billion. This is based on reported shares across multiple companies, which include ArriVent Biopharma, Inc., BeiGene, Ltd., Enfusion, Inc., Apellis Pharmaceuticals, Inc., and CHINA JO-JO DRUGSTORES, INC..
SEC CIK
HILLHOUSE INVESTMENT MANAGEMENT, LTD.'s CIK is 0001510589
Past Insider Trading and Trends
2016 was HILLHOUSE INVESTMENT MANAGEMENT, LTD.'s most active year for acquiring shares with 4 total transactions. HILLHOUSE INVESTMENT MANAGEMENT, LTD.'s most active month to acquire stocks was the month of January. 2023 was HILLHOUSE INVESTMENT MANAGEMENT, LTD.'s most active year for disposing of shares, totalling 8 transactions. HILLHOUSE INVESTMENT MANAGEMENT, LTD.'s most active month to dispose stocks was the month of May. 2017 saw HILLHOUSE INVESTMENT MANAGEMENT, LTD. paying a total of $19,999,994.00 for 8,003,427 shares, this is the most they've acquired in one year. In 2023 HILLHOUSE INVESTMENT MANAGEMENT, LTD. cashed out on 4,154,817 shares for a total of $823,490,197.76, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ArriVent Biopharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.48M |
$18.00 |
—
| 4.48M |
Jan 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BeiGene, Ltd. (BGNE) Snapshot price: $153.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.83% | -1.20M |
$188.88 | -$226,306,339.45 | 142.89M |
Jun 13 - Jun 14
| |||
Form 4
| -2.01% | -2.96M |
$201.98 | -$597,183,858.31 | 144.09M |
Jun 8 - Jun 12
| |||
Form 4
| +0.01% | 7.8K |
—
|
—
| 147.04M |
Aug 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 39.73M |
—
|
—
| 39.73M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Enfusion, Inc. (ENFN) Snapshot price: $7.97
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -11.52% | -647.86K |
$15.90 | -$10,297,766.49 | 4.98M |
Oct 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Apellis Pharmaceuticals, Inc. (APLS) Snapshot price: $66.585
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.53M |
$14.00 |
—
| 3.53M |
Nov 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CHINA JO-JO DRUGSTORES, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||